DR-358 Spatial and longitudinal heterogeneity of liver tumors across ages shaped by interaction between genetics and environment

No Featured Image set

DR-358 Spatial and longitudinal heterogeneity of liver tumors across ages shaped by interaction between genetics and environment

30-10-2024

We aim to decipher the clonal and phenotypic evolution of liver tumors based on genomic analysis of large cohorts (our …

No Featured Image set

DR-419 Characterizing the role of cytidine deaminase in cancer progression and metastasis

30-10-2024

The incidence of cancer is a major health problem worldwide, however the mechanistic basis of cancer development and intervention to …

No Featured Image set

DR-394 Uncovering immunoediting strategies and hallmark ordering underlying metastatic transformation across tumours

30-10-2024

This project seeks to unravel the complex process by which cancer outsmarts the immune system, a critical challenge in cancer …

No Featured Image set

DR-369 A method to infer substitution mutational signatures while correcting for local mutation rates biases

30-10-2024

Vulnerability of the DNA to damage is influenced by (epi)genomic features and tissue specific properties of the DNA repair machinery. …

No Featured Image set

DR-357 Expanded Structural Variant Signatures and their Role in Predicting Chemotherapy Sensitivity

30-10-2024

The type of genetic alteration that affects the largest fraction of the genome in cancer is alterations in chromosome structure, …

No Featured Image set

DR-397 Genomic and transcriptional determinants of chromosomal instability (CIN) in the tumor evolution and progression of GIST and genomically simple sarcomas

29-08-2024

Unlike normal cells, cancer cells frequently display chromosomal instability (CIN), causing genetic material loss or rearrangement during cell division. Our …

No Featured Image set

DR-396 The impact of individual mutational processes on evolution of cancer

06-08-2024

Drug resistance is a major cause of cancer recurrence and related deaths, often due to DNA mutations in cancer cells …

No Featured Image set

DR-399 Molecular signature scores related to intratumor heterogeneity and stemness to improve prognostic accuracy and facilitate the development of more personalized treatment strategies for breast cancer

17-07-2024

We aim to characterize Immuno-evasive stem cells genetic signatures to better understand their behavior within breast cancer. These cells play …

No Featured Image set

DR-407 Liver metastases exhibit a distinct myeloid-dominated tumor microenvironment characterized by dense infiltration of VEGFR1+ VEGF-A-secreting macrophages

17-07-2024

Liver metastases (LM) are a major obstacle for patients with advanced non-squamous non-small cell lung cancer. We stratified 1,713 treatment-naïve …

No Featured Image set

DR-402 Predicting response to immune-checkpoint inhibitors in metastatic cancer using Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score

17-07-2024

Immune checkpoint inhibitors (ICIs) have significantly improved clinical outcomes of patients with metastatic cancers. In clinical practice, three biomarkers are …

No Featured Image set

DR-385 Development of computational multi-omics strategies for targeting therapeutically the tumour metastasis and tumour microenvironment heterogeneity

12-07-2024

Identifying the most appropiate therapies based on cancer genome data is a major challenge in personalized cancer medicine. Physicians and researchers face …

No Featured Image set

DR-375 AI-driven classification of metastatic tumors with MSI/MSS phenotypes: an integrative computational and clinical perspective

12-07-2024

We aim to provide insights into cancer progression and therapy responsiveness by combining diverse molecular sequence data using an AI-driven multimodal classifier. …

Terug naar het laatste nieuws

Wilt u op de hoogte blijven van nieuwe ontwikkelingen?

Abonneer u op onze nieuwsbrieven

Meer weten over de complete DNA-test?

Ga naar OncoAct.nl